Mayo Clinic
Phenomix, Mayo Clinic Ink Licensing Deal for Obesity Phenotype Blood Test
Phenomix said its MyPhenome test uses a multiomics and artificial intelligence platform to predict patients' obesity phenotypes.
WuXi Diagnostics Closes $150M Series B Financing Round
The Chinese company said it would use some of the funding to advance its integrated diagnostics research and development pipeline.
BRCA2 Variants of Unknown Significance Reclassified Through Functional Data Additions
Researchers reclassified 86 percent of variants initially determined to be VUS, potentially changing surveillance or treatment approaches for patients.
Stella Diagnostics, Mayo Clinic Collaborating on Barrett's Esophagus Protein Markers
The partners will use mass spec to look at markers in Barrett's patients who either progressed to more severe disease states or remained stable over a 10-year period.
Cue Health Ramping Up COVID-19 Test Production Following Positive Mayo Clinic Study, DoD Funding
Premium
The test uses isothermal nucleic acid amplification to return results in 20 minutes at the point of care, and demonstrated 98 percent agreement with PCR testing.
Feb 12, 2020
Jan 29, 2020
Jan 9, 2020